- People who have type 2 diabetes are at an increased risk of developing dementia.
- A recent study investigates how a diabetes medication may affect this risk.
- The scientists behind the study focused on sodium-glucose cotransporter-2 (SGLT-2) inhibitors, which they found significantly reduced dementia risk compared with another diabetes drug.
- The longer an individual had been taking the drug, the greater the protective effect was.
The results of a new large-scale study published in
Read the full article here